Lipid Management

Programme Brief

From 2021 the 15 AHSN’s will focus on enabling the NHS to optimise lipid management in people at increased cardiovascular risk. To support these long term ambitions through a CVD Programme (led by the team at North East and North Cumbria AHSN), the objectives are;To increase the numbers of those who have their cholesterol measured and to identify those with...

From 2021 the 15 AHSN’s will focus on enabling the NHS to optimise lipid management in people at increased cardiovascular risk. To support these long term ambitions through a CVD Programme (led by the team at North East and North Cumbria AHSN), the objectives are;

To increase the numbers of those who have their cholesterol measured and to identify those with conditions that increase familial risk of hypercholesterolaemia
To reduce the risk for heart attacks and strokes occurring
To reduce the risk of admissions and re-admissions associated with cardiovascular disease
To reduce health inequalities by ensuring a consistent, national approach to lipid management, using a NICE approved clinical pathway
To provide more treatment options to high-risk patients who remain at risk despite maximum tolerated statin therapy.

Across Wessex, delivery of the programme will incorporate AF activity already established and brings together work to support the NHS Accelerated Access Review Rapid Uptake Product (AAC RUP). The Rapid Uptake Product element of the programme is a novel, NICE-approved clinical pathway, focusing on secondary prevention.

Read more

Educational Videos

We've produced a series of videos to support the education and management of cardiovascular disea... Find out more >

Background

The Wessex AHSN lipid management will focus on pathway improvement for hyperlipidaemia management... Find out more >

Resources at a Glance

For further information about our Lipid Optimisation including background reading, resources to s... Find out more >

National Guidance, Supporting Policies and Contractual Frameworks

The NICE guideline CG181 includes recommendations on risk assessment for CVD and on the use of ... Find out more >

Clinical Pathways

To support delivery of this part of the NHS Long-Term Plan, the Accelerated Access Collaborative ... Find out more >

Meet the team

See all of our programmes

Latest news

Tackling Cholesterol Together launches education programme for primary care

The NHS Accelerated Access Collaborative (AAC) and The AHSN Network are partnering with the ...

Read more

Featured video

The AHSN Network supports the AAC with Lipid Management

Browse all videos

Resources

Lipid Management Pathways - Dorset.pdf

MHH Imp Report - Final 20-6-23.pdf

Publications

FAMCAT2 Identifying patients at risk of familial hypercholesterolaemia

AAC AHSN Network Lipid Management and FH programme impact report

Cookies help us improve your Health Innovation Wessex online experience. If you accept their use, continue using our site. Or, find out more about cookies.